Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
xmab 5871 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lupus Erythematosus Systemic[MeSHID:D008180] Diabetes Autoimmune[MeSHID:D003922] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] |
NA | phase 2 | unknown |
xmab 5871 | immunoglobulin gamma fc receptor iib | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lupus Erythematosus Systemic[MeSHID:D008180] Diabetes Autoimmune[MeSHID:D003922] Disease[MeSHID:D004194] Rheumatoid Arthritis[MeSHID:D001172] |
NA | phase 2 | unknown |
click here to return to the previous page |